ALLR - Allarity Therapeutics appoints co-founder Thomas Jensen as interim CEO
2023-12-12 06:09:27 ET
More on Allarity Therapeutics
- Allarity stock soars 60% premarket on ovarian cancer therapy results
- Seeking Alpha’s Quant Rating on Allarity Therapeutics
- Historical earnings data for Allarity Therapeutics
- Financial information for Allarity Therapeutics
For further details see:
Allarity Therapeutics appoints co-founder Thomas Jensen as interim CEO